COMPANIES COVERED
Glaxo SmithKline (GSK)Download FREE Report Sample
Download Free sampleBipolar disorder (formerly called manic-depressive illness or manic depression) is a mental disorder that causes unusual shifts in mood, energy, activity levels, concentration, and the ability to carry out day-to-day tasks.
Bipolar Disorder Market contains market size and forecasts of Bipolar Disorder in Global, including the following market information:
Global Bipolar Disorder Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Bipolar Disorder market was valued at 5948.3 million in 2021 and is projected to reach US$ 7116 million by 2028, at a CAGR of 2.6% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Bipolar I Disorder Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Bipolar Disorder include Glaxo SmithKline (GSK), Pfizer Inc., Janssen Pharmaceuticals, Eli Lilly, Allergan Plc., Novartis AG, AbbVie Inc., Otsuka Holdings Ltd and AstraZeneca. etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Bipolar Disorder companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Bipolar Disorder Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Bipolar Disorder Market Segment Percentages, by Type, 2021 (%)
Bipolar I Disorder
Bipolar II Disorder
Cyclothymic Disorder
Global Bipolar Disorder Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Bipolar Disorder Market Segment Percentages, by Application, 2021 (%)
Mood Stabilizers
Anticonvulsants
Antipsychotic drugs
Antidepressant drugs
Antianxiety drugs
Others
Global Bipolar Disorder Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Bipolar Disorder Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Bipolar Disorder revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Bipolar Disorder revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Glaxo SmithKline (GSK)
Pfizer Inc.
Janssen Pharmaceuticals
Eli Lilly
Allergan Plc.
Novartis AG
AbbVie Inc.
Otsuka Holdings Ltd
AstraZeneca
Speak to our Custom Research Team and get the Custom Research in a budget
Custom ResearchFrequently Asked Questions ?
A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.
A license granted to multiple users.
A license granted to a single business site/establishment.
A license granted to all employees within organisation access to the product.
Upto Working 24 to 48 hrs
Upto 72 hrs max - Weekends and Public Holidays
Online Payments with PayPal and CCavenue
Wire Transfer/Bank Transfer
Hard Copy
Industry Market SizeSWOT AnalysisIndustry Major PlayersRevenue ForecastsHistorical and Forecast GrowthProfitability Analysis
